WCN25-744 FELZARTAMAB SELECTIVELY AND POTENTLY TARGETS CD38+ ANTIBODY SECRETING CELLS FROM PATIENTS WITH IMMUNE-MEDIATED KIDNEY DISEASES

WCN25-744 FELZARTAMAB SELECTIVELY AND POTENTLY TARGETS CD38+ ANTIBODY SECRETING CELLS FROM PATIENTS WITH IMMUNE-MEDIATED KIDNEY DISEASES

Saved in:

Bibliographic Details
Main Authors:	Kristina Ilieva, Karin Landgraf, Rainer Boxhammer, Stefan Steidl, Donna Flesher
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924023520
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN25-318 FELZARTAMAB DURABLY REDUCES DISEASE RELEVANT BIOMARKERS THROUGH TARGETING OF CD38+ PLASMA CELLS AND PLASMABLASTS, THE UPSTREAM DRIVERS OF IgA NEPHROPATHY (IgAN)
by: Lisa Kivman, et al.
Published: (2025-02-01)

WCN25-843 FELZARTAMAB REDUCES aPLA2R Ab BY SELECTIVELY DEPLETING CD38+ PLASMA CELLS AND PLASMABLASTS, THE MAIN PATHOGENIC CELLULAR DRIVERS OF DISEASE IN PRIMARY MEMBRANOUS NEPHROPATHY (PMN)
by: Donna Flesher, et al.
Published: (2025-02-01)

WCN25-844 FELZARTAMAB FOR IgA NEPHROPATHY: FINAL RESULTS OF THE IGNAZ STUDY
by: Uptal Patel, et al.
Published: (2025-02-01)

The Otuken Uyghur Empire (744-840)
by: Dilyaram Ayupova
Published: (2022-10-01)

Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody–Positive Primary Membranous Nephropathy
by: Brad H. Rovin, et al.
Published: (2024-09-01)

Experimental Investigation of R744 Ejector Efficiency
by: Zhang Jinrui, et al.
Published: (2016-01-01)

Research on Performance of Heat Pump Systems Using R744 /R600 and R744 /R600a Mixtures as Refrigerants
by: Fan Xiaowei, et al.
Published: (2011-01-01)

WCN25-3908 WHEN HYPERTENSION HIDES A DEADLY SECRET
by: Aleena Rose Joy, et al.
Published: (2025-02-01)

WCN24-744 AGREEMENT BETWEEN DIETARY RECORDS AND MARONI´S FORMULA AS METHODS TO ESTIMATE PROTEIN INTAKE IN PATIENTS WITH CHRONIC KIDNEY DISEASE
by: María Clara Delucchi, et al.
Published: (2024-04-01)

Experimental Investigation of High-power R744 Compressor Efficiencies at Varied Revolutions
by: Han Yi, et al.
Published: (2017-01-01)

P744: Cytomictical chimerism in a phenotypically normal 46,XY woman
by: Caio Robledo Quaio, et al.
Published: (2025-01-01)

Transcritical R744 Supermarket Refrigeration System Integrated with a Heat-Driven Ejector Chiller
by: Ayan Sengupta, et al.
Published: (2025-03-01)

Demographic characteristics, site and phylogenetic distribution of dogs with appendicular osteosarcoma: 744 dogs (2000-2015).
by: Joanne L Tuohy, et al.
Published: (2019-01-01)

Targeting CD38 in Antibody-Mediated Rejection
by: Katharina A. Mayer, et al.
Published: (2025-05-01)

WCN25-627 Effects of Irisin secretion on the development of renal injury in a mouse model of uremic sarcopenia
by: Teruyuki Okuma, et al.
Published: (2025-02-01)

The Situation of the Kurdish Residencies During the Conflict of Bwayhy Princes (334 -744 AH/ 946-1055 AD)
by: Diyar Maher Tahir Maher, et al.
Published: (2024-04-01)

Deletion of CD38 enhances CD19 chimeric antigen receptor T cell function
by: Kimberly Veliz, et al.
Published: (2024-06-01)

CD38 Ligation in Peripheral Blood Mononuclear Cells of Myeloma Patients Induces Release of Protumorigenic IL-6 and Impaired Secretion of IFNγ Cytokines and Proliferation
by: Giorgio Fedele, et al.
Published: (2013-01-01)

Performance Assessment of R-454C, R-449A, and R-744 in Food Retail Refrigeration Systems
by: William Ferretto, et al.
Published: (2025-01-01)

The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas
by: Liyun Lin, et al.
Published: (2025-02-01)

CD19+CD24hiCD38hi B Cell Dysfunction in Primary Biliary Cholangitis
by: Qubo Chen, et al.
Published: (2020-01-01)

TIM‐4 increases the proportion of CD4+CD25+FOXP3+ regulatory T cells in the pancreatic ductal adenocarcinoma microenvironment by inhibiting IL‐6 secretion
by: Ziyao Wang, et al.
Published: (2024-09-01)

CD27 on IgD-CD38-B Cells Mediates the Coprococcus-COPD Link
by: Gao Y, et al.
Published: (2025-07-01)

WCN25-3396 PREVALENCE OF PROTEINURIA IN SOUTHERN MALAYSIA: AN OBSERVATIONAL STUDY
by: XIAN PEI CHEONG, et al.
Published: (2025-02-01)

Nicotinamide Riboside and CD38: Covalent Inhibition and Live-Cell Labeling
by: Guoyun Kao, et al.
Published: (2024-10-01)

Early boosting of p38 MAPK signaling pathway by lycorine hydrochloride potently inhibits PRRSV proliferation in primary and established cells
by: Lizhan Su, et al.
Published: (2025-08-01)

WCN25-4233 THE FITNESS PARADOX
by: Swetha rajkumar, et al.
Published: (2025-02-01)

WCN25-1136 FRAILTY IN CKD
by: Beatriz Mendes, et al.
Published: (2025-02-01)

Reduced microRNA-744 expression in mast cell-derived exosomes triggers epithelial cell ferroptosis in acute respiratory distress syndrome
by: Xiaobin Fang, et al.
Published: (2024-11-01)

CD38/cADPR Signaling Pathway in Airway Disease: Regulatory Mechanisms
by: Deepak A. Deshpande, et al.
Published: (2018-01-01)

CD38 deletion to preserve CAR T cell metabolism and promote functional persistence
by: Viviana Rubino, et al.
Published: (2024-09-01)

Anti-CD19 CAR T cells potently redirected to kill solid tumor cells.
by: Christine Ambrose, et al.
Published: (2021-01-01)

CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies in multiple myeloma
by: Giulia Giorgetti, et al.
Published: (2025-05-01)

Nuclear CD24 promotes IL-6 secretion in fibroblasts
by: Yuqiao Sheng, et al.
Published: (2025-04-01)

Marked elevation of circulating CD19+CD38hiCD24hi transitional B cells give protection against neonatal sepsis
by: Sitao Li, et al.
Published: (2018-06-01)

Human CD38hiCD138+ Plasma Cells Can Be Generated In Vitro from CD40-Activated Switched-Memory B Lymphocytes
by: Rayelle Itoua Maïga, et al.
Published: (2014-01-01)

CD38‐NADase is a new major contributor to Duchenne muscular dystrophic phenotype
by: Antoine de Zélicourt, et al.
Published: (2022-03-01)

CD38 contributes to tumor progression and tumor microenvironment reshaping in epithelial ovarian cancer
by: Wei Wang, et al.
Published: (2025-07-01)

Apigenin inhibits NLRP3 inflammasome activation in monocytes and macrophages independently of CD38
by: Knut Husø Lauritzen, et al.
Published: (2025-01-01)

Myeloid but not hepatocytic CD38 is a key driver for hepatic ischemia/reperfusion injury
by: Qi-Hang Zhao, et al.
Published: (2025-05-01)